Mydriatic Agent: Clinical Trials

7 trials of Mydriatic Agent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. .

Follow Mydriatic Agent: new trials by email Literature Review of Mydriatic Agent trials Research Report on Mydriatic Agent

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
Mydriatic Agent, Color Fundus Photography, EyeCheckup v2.0 - Glaucoma, Age-Related Macular Degeneration
CompletedUral Telekomunikasyon Sanayi Ticaret Anonim Sirketi15282023-03-012024-05-14
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
Color fundus photograph, Optical Coherence Tomography (OCT) of the retina, Mydriatic Agent - Diabetes, Diabetic Retinopathy
CompletedRETINA-AI Health, Inc.11002022-11-032023-10-16
Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
Color Fundus Photography, Mydriatic Agent, EyeCheckup - AI Based DR Screening - Diabetic Retinopathy, Diabetic Eye Problems
CompletedUral Telekomunikasyon Sanayi Ticaret Anonim Sirketi9002022-02-012024-07-15
Assessment of EyeArt Performance With Retinal Cameras
Retinal imaging, Mydriatic Agent - Diabetic Retinopathy
CompletedEyenuk, Inc.2462021-07-132022-11-09
Assessment of EyeArt Performance With Retinal Imaging Devices
Color fundus photography, Mydriatic Agent - Diabetic Retinopathy
CompletedEyenuk, Inc.622019-12-182021-07-08
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
Color fundus photography, Mydriatic Agent - Diabetic Retinopathy, Diabetic Eye Problems
CompletedEyenuk, Inc.9422017-04-172018-07-30
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
Color fundus photography, Mydriatic Agent - Diabetic Retinopathy
CompletedEyenuk, Inc.522017-02-172018-07-30

Conditions studied

Diabetic Retinopathy (7)  ·  Diabetes Mellitus (1)  ·  Eye Diseases (1)  ·  Glaucoma (1)  ·  Macular Degeneration (1)  ·  Retinal Vein Occlusion (1)

Sponsors

Eyenuk, Inc. (4)  ·  Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi (2)  ·  RETINA-AI Health, Inc. (1)

Countries

United States (5)  ·  Turkey (Türkiye) (2)

Top investigators

A Burak Bilgin, Assoc. Prof. (1)

Results publications

PMID 38467864, PMID 41541002

NIH funding

9SB1EY027241 (2), R44EY026864 (2)